APA (7th ed.) Citation

YESILYURT-DIRICAN, Z. E., KARAOMERLIOGLU, I., ERDOGAN-VADACCA, B. R., OZTURK, G., MICHEL, M. C., & ARIOGLU-INAN, E. (2026). Lack of evidence for improved β-adrenoceptor-mediated papillary muscle contraction by low-dose empagliflozin treatment in a rat model of streptozotocin-induced diabetes. Journal of Research in Pharmacy, 30(1), 60. https://doi.org/10.12991/jrespharm.1844982

Chicago Style (17th ed.) Citation

YESILYURT-DIRICAN, Zeynep Elif, Irem KARAOMERLIOGLU, Betül Rabia ERDOGAN-VADACCA, Gaye OZTURK, Martin Christian MICHEL, and Ebru ARIOGLU-INAN. "Lack of Evidence for Improved β-adrenoceptor-mediated Papillary Muscle Contraction by Low-dose Empagliflozin Treatment in a Rat Model of Streptozotocin-induced Diabetes." Journal of Research in Pharmacy 30, no. 1 (2026): 60. https://doi.org/10.12991/jrespharm.1844982.

MLA (9th ed.) Citation

YESILYURT-DIRICAN, Zeynep Elif, et al. "Lack of Evidence for Improved β-adrenoceptor-mediated Papillary Muscle Contraction by Low-dose Empagliflozin Treatment in a Rat Model of Streptozotocin-induced Diabetes." Journal of Research in Pharmacy, vol. 30, no. 1, 2026, p. 60, https://doi.org/10.12991/jrespharm.1844982.